Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

OBJECTIVE: Current non-invasive diagnostic tests can distinguish between pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two thirds of patients. We have searched for blood-derived metabolite biomarkers for this diagnostic purpose. DESIGN: For a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayerle, Julia, Kalthoff, Holger, Reszka, Regina, Kamlage, Beate, Peter, Erik, Schniewind, Bodo, González Maldonado, Sandra, Pilarsky, Christian, Heidecke, Claus-Dieter, Schatz, Philipp, Distler, Marius, Scheiber, Jonas A, Mahajan, Ujjwal M, Weiss, F Ulrich, Grützmann, Robert, Lerch, Markus M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Pancreas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754849/
https://www.ncbi.nlm.nih.gov/pubmed/28108468
http://dx.doi.org/10.1136/gutjnl-2016-312432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754849/
https://www.ncbi.nlm.nih.gov/pubmed/28108468
http://dx.doi.org/10.1136/gutjnl-2016-312432

Ejemplares similares